RecruitingPhase 3NCT07654374A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsAlbany, NY · Brooklyn, NY · +71 more sites
RecruitingPhase 2NCT07783802A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular EventSponsor: Eli Lilly and CompanyBuffalo, NY · The Bronx, NY · +28 more sites
RecruitingPhase 3NCT07662135A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background DapagliflozinSponsor: AstraZenecaThe Bronx, NY · +32 more sites
RecruitingNot applicableNCT06513026Milk for Diabetes PreventionSponsor: Albert Einstein College of MedicineThe Bronx, NY
Not yet recruitingPhase 3NCT07668336A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 DiabetesSponsor: Eli Lilly and CompanySyracuse, NY · The Bronx, NY · +15 more sites